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Available online 3 January 2016Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disease primarily affecting the cerebellum.Very little
is known about the molecular mechanisms underlying the disease and, to date, no cure or treatment is available.
Here, we demonstrate the generation of an induced pluripotent stem cell (iPSC) line of a SCA2 patient. The select-
ed clone has been proven to be a bona ﬁde iPSC line, which retains a normal karyotype. Due to its differentiation
potential into neurons, this iPSC line will be a valuable tool in studying a disease-speciﬁc phenotype of SCA2.
© 2015 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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Human skin ﬁbroblasts, obtained by skin biopsy of a symptomatic,
male 33-year-old spinocerebellar type 2 (SCA2) patient (anonymized as
H271), were reprogrammed using episomal vectors carrying transcripts
for human OCT4, SOX2, KLF4, L-MYC, LIN28, and small hairpin RNA for
TP53 (Okita et al., 2011). The clone described in this publication was
termed H271 clone (c) 1. The absence of the reprogramming plasmids
was conﬁrmed by quantitative PCR (qPCR) on genomic DNA (Fig. 1A).
SCA2 is a dominantly inherited neurodegenerative disorder caused
by amutation in the ATXN2 gene. Normal alleles contain 22 CAG repeats
with CAA interruptions (also coding for glutamine), whereas disease
causing alleles contain trinucleotide repeats of 33 ormore CAGs (usually
without any CAA interruptions) (Pulst et al., 1996). The repeat lengths
for patient H271 were determined to be 22 and 44 by fragment length
analysis (data not shown) and conﬁrmed to be present also in iPSC
line H271 c1 by sequencing both alleles individually (Fig. 1B).
Furthermore, the expression of key pluripotency genes was observed
both onRNA, aswell as protein level, as demonstrated by qRTPCR analysis
and immunocytochemistry, respectively (Fig. 1C and D). Additionally, the
cells had the capacity to form derivatives of all three germ layers upon
embryoid body differentiation (Fig. 1E). Taken together, this validates
the true pluripotent potential of the generated iPSC line.
3. Materials and methods
3.1. Reprogramming using episomal vectors
Fibroblasts were cultured in ﬁbroblast medium, consisting of
Dulbecco's Modiﬁed Eagle Medium (DMEM) supplemented with 10%C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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streptomycin (Pen/Strep). 1 × 105 ﬁbroblasts were electroporated
with a total of 1 μg of episomal plasmids containing hOCT4 with a
short hairpin to TP53 (shP53; Addgene plasmids 27077 and 27076,
respectively), hSOX2 and hKLF4 (Addgene plasmid 27078), and hL-
MYC and hLIN28 (Addgene plasmid 27080), (Okita et al., 2011), and
cultured in ﬁbroblast medium. Electroporation was carried out
using a Neon™ electroporation device with two pulses at 1200 V
for 20 ms (Life Technologies). One week after electroporation, ﬁbro-
blasts were trypsinized and split 1:2 onto matrigel-coated dishes
(BD Biosciences) and cultured in E8 medium (Gibco) under hypoxic
conditions. After four weeks, primary iPSC colonies were picked to
establish stable clones.
3.2. Integration of episomal vectors
DNA for integration analysis was puriﬁed from ﬁbroblasts and iPSCs
using theDNeasy Blood and Tissue kit (QIAGEN). Datawas plottedusing
the delta delta Ct algorithm, 2(−ΔΔCt) with ﬁbroblasts and GAPDH as ref-
erences. The following primers were used:O
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Sanger sequencing of a 300 base pair region around the CAG repeat
region of the ATXN2 gene was carried out in an ABI PRISM 310 Genetic
Analyzer using the primers SCA2 seq2 forward 5′-CTTGGTCTCGGCGG
GC-3′ and SCA2 seq2 reverse 5′-GAGGAGACCGAGGACGAGG-3′.
3.4. RNA extraction, cDNA synthesis, and quantitative real-time PCR (qRT-PCR)
RNA was extracted using RNeasy Mini (QIAGEN) and cDNA synthe-
sis was performed using Revert Aid First Strand cDNA synthesis kit
(Thermo Scientiﬁc) according to the manufacturers' protocols. qRT-
PCR was carried out using LightCycler 480 SYBR Green I Master
(Roche). Data was plotted using the delta delta Ct algorithm, 2(−ΔΔCt).
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Immunocytochemistry was performed as previously described
(Marthaler et al., 2013). The following primary antibodies were used:
Anti-OCT4 (Santa Cruz, sc 8628); anti-NANOG (Peprotech, 500P236);
anti-TRA1-60 (BioLegend, 330602); anti-SSEA4 (BioLegend, 330402);
anti-TUBB3 (Millipore, MAB1637); anti-SMA (Dako, M0851), and anti-
SOX17 (Santa Cruz, sc17355); all 1:500. Secondary antibodies used were:
Alexa Fluor 594 rabbit anti-goat (A21223) and goat anti-rabbit (A11072),
Alexa Fluor 488 donkey anti-rabbit (A21206), donkey anti-goat (A11055),
and goat anti-mouse (A11017), all 1:2000, (all Invitrogen).
3.6. Embryoid body differentiation
iPSCs growing in E8 medium (Gibco) on matrigel (Corning Biosci-
ence) were dissociated with EDTA (Gibco) and allowed to form aggre-
gates in none-coated cell culture dishes. On day 3, aggregates were
transferred to matrigel-coated dishes andmediumwas switched to dif-
ferentiation medium: DMEM/F12 containing 20% FBS, L-glutamine, and
non-essential amino acids (all Gibco) for meso- and endoderm induc-
tion, or DMEM/F12 containing 50% neurobasal medium, B27, N2, and
L-glutamine (all Gibco) for ectoderm induction. Cells were ﬁxed for im-
munocytochemistry on day 14.
3.7. Veriﬁcation and authentication
An intact genome with no detectable abnormalities was demon-
strated by karyotyping using G-banding (Fig. 1F). Analysis was per-
formed by Cell Guidance Systems, Cambridge, UK.
3.8. Ethical approval
The study was approved by the regional scientiﬁc ethical committee in
the Capital Region of Denmark (RH), (protocol number H-4-2011-157), Co-
penhagen, Denmark, andwritten informed consentwas obtained in all cases.
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